The Hôpital de l'Enfant-Jésus is a hospital located in Maizerets, a neighborhood of the district of La Cité-Limoilou in Quebec City, Quebec, Canada. It is one of only 3 hospitals in the province with a Level 1 Trauma Center.

There are 525 beds in Hopital de L'Enfant Jesus.

During the past decade, Hopital de L'Enfant Jesus conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 28 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 18 clinical trials were completed. i.e. 72% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital de L'Enfant Jesus" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Hopital de l'Enfant-Jesus" with 7 trials sponsored, "Ottawa Hospital Research Institute" with 6 trials sponsored, "McMaster University" with 4 trials sponsored and "Sunnybrook Health Sciences Centre" with 4 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de L'Enfant Jesus" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 15 trials as a collaborator, "Canadian Critical Care Trials Group" with 4 trials as a collaborator, "Alzheimer's Association" with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "National Institute on Aging (NIA)" with 3 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 84 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de L'Enfant Jesus" are "Alzheimer's Disease" (9 trials), "Atrial Fibrillation" (4 trials), "Deep Venous Thrombosis" (4 trials), "Alzheimers Disease" (3 trials) and "Alzheimers Disease, Familial" (3 trials). Many other conditions were trialed in "Hopital de L'Enfant Jesus" in a lesser frequency.

Most popular intervention types in "Hopital de L'Enfant Jesus" are "Drug" (75 trials), "Device" (16 trials), "Other" (15 trials), "Procedure" (13 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Cyclophosphamide" (7 trials), "Rituximab" (7 trials), "Gantenerumab" (5 trials) and "Bendamustine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de L'Enfant Jesus" are 105 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital de L'Enfant Jesus". undefined are not yet recruiting, 20 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Hopital de L'Enfant Jesus, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de L'Enfant Jesus, 8 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 16 trials that are defined as “Not Applicable".